$RNAC Cashflow Statement | Understand Stock

$RNAC

$6.69 +$0.23 (3.56%) Close

$RNAC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Amortization of premiums and discounts on marketable securities
Non‑cash lease expense
Impairment of Right of use asset
Impairment of long-lived assets
Loss on disposal of property and equipment
Impairment of indefinite-lived intangible and long-lived assets
Stock‑based compensation expense
Non-cash interest expense
Gain on change in fair value of warrant liabilities
Loss on change in fair value of CVR liability
Loss on extinguishment of debt
Net realized losses on marketable securities
Loss on change in fair value of forward contract liabilities
Loss on impairment of investment
(Benefit) provision for deferred taxes
Changes in operating assets and liabilities:
Accounts receivable
Unbilled receivable
Prepaid expenses and other assets
Accounts payable
Income taxes payable
Deferred revenue
Accrued expenses and other liabilities

Net cash used in operating activities
Cash flows from investing activities
Cash assumed in acquisition of Old Cartesian
Proceeds from maturities of marketable securities
Payment made for investments
Purchases of marketable securities
Sales of marketable securities
Purchases of property and equipment
Proceeds from the sale of property and equipment
Net cash used in investing activities

Cash flows from financing activities
Proceeds from issuance of long-term debt, net of expenses
Proceeds from issuance of Series A Preferred Stock, gross in private placement
Repayments of principal, final payment fee, and prepayment penalty on debt
Debt amendment fee included in debt discount
Other financing fees
Net proceeds from issuance of common stock- at-the-market offering
Stock Offering, Excluding At The Market Offering And Private Placement
At-The-Market Offering
Total net proceeds from issuance of common stock- at-the-market offering

Net proceeds from issuance of common stock and Series B Preferred Stock in private placement
Equity offering costs
Proceeds from exercise of common warrants
Settlement of outstanding equity awards at Merger
Proceeds from exercise of stock options
Proceeds from issuance of common stock under Employee Stock Purchase Plan
Distribution of Contingent Value Rights
Net cash (used in) provided by financing activities

Effect of exchange rate changes on cash
Net change in cash, cash equivalents, and restricted cash
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Cash paid for interest
Non-cash investing and financing activities
Issuance of common stock, license agreement in stock-based compensation expense
Cashless warrant exercise
Reclassification of warrant liability to equity
Purchase of property and equipment not yet paid
Unrealized loss on marketable securities
Debt issuance costs in accrued liabilities
Equity offering costs in accrued liabilities
Operating lease right-of-use assets obtained in exchange for operating lease liabilities

Comments